Find a Tender
complete
Official procurement procedure
NHS National Framework for Transition products commencing 1 February 2025
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Framework for Transition products commencing 1 February 2025". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
6.1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 182 active published awards; 180 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published21 Jan 2025, 16:16 GMT | Last source update21 Jan 2025, 16:16 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-04a41a | ||
What is being bought
Project title: NHS National Framework for Transition products commencing 1 February 2025<br/>Offer reference number: CM/TNS/24/5713<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection<br/><br/>Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
What changed
From the official release history
- tender value changed
21 Jan 2025, 16:16 GMT - Status changed to complete
21 Jan 2025, 16:16 GMT - Official notice release published
21 Jan 2025, 16:16 GMT - Submission deadline changed to published date
21 Jan 2025, 16:16 GMT - Published value updated to £28,320,000
30 Sept 2024, 12:02 BST - Status changed to active
30 Sept 2024, 12:02 BST - Official notice release published
30 Sept 2024, 12:02 BST - Submission deadline changed to 30 Oct 2024, 13:00 GMT
30 Sept 2024, 12:02 BST - Buyer information updated
30 Sept 2024, 12:02 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedProject title: NHS National Framework for Transition products commencing 1 February 2025<br/>Offer reference number: CM/TNS/24/5713<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection<br/><br/>Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS EnglandContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
21 Jan 2025, 16:16 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 14 Jan 2025, 00:00 GMT · £1 - Contract active
Signed 14 Jan 2025, 00:00 GMT · £1 - Contract active
Signed 14 Jan 2025, 00:00 GMT · £1 - Contract active
Signed 14 Jan 2025, 00:00 GMT · £1 - Contract active
Signed 14 Jan 2025, 00:00 GMT · £1 - Contract active
Signed 14 Jan 2025, 00:00 GMT · £1
Commercial outcome and competition
Awards Sun Pharma UK Ltd Not published · Not published · active Thornton and Ross Ltd Not published · Not published · active Dr.Reddy's Laboratories (UK) Limited Not published · Not published · active Zentiva Pharma UK Ltd Not published · Not published · active Biocon Not published · Not published · active Baxter Healthcare Ltd Not published · Not published · active |
Contracts Contract £1 · signed 14 Jan 2025, 00:00 GMT · active Contract £1 · signed 14 Jan 2025, 00:00 GMT · active Contract £1 · signed 14 Jan 2025, 00:00 GMT · active Contract £1 · signed 14 Jan 2025, 00:00 GMT · active Contract £1 · signed 14 Jan 2025, 00:00 GMT · active Contract £1 · signed 14 Jan 2025, 00:00 GMT · active |
Bid statistics bids: 13 (lot 1) bids: 13 (lot 1) bids: 13 (lot 1) bids: 13 (lot 1) bids: 13 (lot 1) bids: 13 (lot 1) electronicBids: 13 (lot 1) electronicBids: 13 (lot 1) electronicBids: 13 (lot 1) electronicBids: 13 (lot 1) electronicBids: 13 (lot 1) electronicBids: 13 (lot 1) foreignBidsFromEU: 13 (lot 1) foreignBidsFromEU: 13 (lot 1) foreignBidsFromEU: 13 (lot 1) foreignBidsFromEU: 13 (lot 1) foreignBidsFromEU: 13 (lot 1) foreignBidsFromEU: 13 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) smeBids: 5 (lot 1) |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-FTS-107961Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published